Results 61 to 70 of about 4,177 (192)

The effectiveness of ultrasound‐guided injection of BTX‐A in the management of sialorrhea in neurogenic dysphagia patients

Laryngoscope Investigative Otolaryngology, 2023
Objective To evaluate the effectiveness of ultrasound‐guided injection of botulinum toxin type A (BTX‐A) in treating sialorrhea. Methods We recruited 32 sialorrhea subjects and they received an ultrasound‐guided injection of BTX‐A.
Zitong He, Suling Chen, Peishan Zeng, Meng Dai, Xiaomei Wei, Jiemei Chen, Xue Zhang, Zulin Dou, Hongmei Wen, Chao Li   +9 more
doaj   +1 more source

Assessment of Cannabidiol Supplements Use in Small Animals Practice in Portugal

Journal of Animal Physiology and Animal Nutrition, EarlyView.
ABSTRACT This study aimed to assess the current use of cannabidiol supplements (CBDS) by Portuguese small animal veterinary practitioners. An anonymous online survey questioning the frequency of CBDS use, purpose of use and the perceived outcome was developed using Microsoft Forms, and targeted veterinarians currently working in small animal clinics in
Maria Inês Santos, Ana Luísa Lourenço
wiley   +1 more source

Antipsychotics‐Induced Hyposalivation Mediated by Impaired Salivary Ca2+ Signaling

Oral Diseases, EarlyView.
ABSTRACT Objectives Antipsychotic‐induced salivary dysfunction such as hyposalivation is a prevalent clinical challenge that severely compromises oral health and quality of life. Although typical and atypical antipsychotics have their therapeutic target in the central nervous system, their direct molecular mechanisms within the salivary glands remain ...
Chaelin Chung, Soohyun Kim, Yoo‐Bin Kim, Hee‐Kyung Park, Se‐Young Choi   +4 more
wiley   +1 more source

Validation of the Hamilton Anxiety and Depression Rating Scales in Oral Lichen Planus: A Multicenter Study by the Italian Society of Oral Pathology and Medicine

Oral Diseases, EarlyView.
ABSTRACT Objective To assess the psychometric performance of the Hamilton Anxiety Rating Scale (HAM‐A) and Hamilton Depression Rating Scale (HAM‐D) in patients with oral lichen planus (OLP) according to clinical phenotype. Methods This multicenter SIPMO case–control study included 395 participants: 132 patients with keratotic OLP (K‐OLP), 131 with non ...
Daniela Adamo, Gennaro Musella, Federica Canfora, Elena Calabria, Simone Liguori, Carlo Lajolo, Gioele Gioco, Giulia Ottaviani, Katia Rupel, Matteo Biasotto, Margherita Gobbo, Maddalena Manfredi, Paolo Vescovi, Amerigo Giudice, Cristina D'Antonio, Paolo Arduino, Alessio Gambino, Monica Pentenero, Olga Anna Furchì, Davide Bartolomeo Gissi, Andrea Gabusi, Lorenzo Azzi, Angelo Tagliabue, Gianluca Tenore, Andrea Santarelli, Andrea Sardella, Elena M. Varoni, Giovanni Lodi, Giuseppina Campisi, Vera Panzarella, Michele Giuliani, Lorenzo Lo Muzio, Massimo Aria, Luca D'Aniello, Michele Davide Mignogna, Umberto Romeo, SIPMO (Italian Society of Oral Pathology and Medicine)   +36 more
wiley   +1 more source

Real-World Observational Analysis of Clinical Characteristics and Treatment Patterns of Patients with Chronic Sialorrhea

Toxins
Chronic sialorrhea is a condition characterized by excessive drooling, often associated with neurological and neuromuscular disorders such as Parkinson’s disease, cerebral palsy, and stroke.
Michael A. Hast, Amanda M. Kong, Jenna Abdelhadi, Rohan Shah, Andrew Szendrey, Jordan Holmes   +5 more
doaj   +1 more source

Consensus Guidelines for Diagnosis and Management of Pyruvate Dehydrogenase Complex Deficiency

Journal of Inherited Metabolic Disease, Volume 49, Issue 6, November 2026.
ABSTRACT Primary pyruvate dehydrogenase complex deficiency (PDCD) comprises a group of monogenic disorders caused by pathogenic variants in genes encoding subunits of, or regulatory components affecting, the pyruvate dehydrogenase complex. The clinical phenotype spans a broad continuum, ranging from early onset congenital lactic acidosis to infantile ...
Nandaki Keshavan, Julia Neugebauer, Marcello Bellusci, Enrico Bertini, Garry Brown, Niklas Darin, Suzanne DeBrosse, Lucy Drexler, Stefan Drexler, Gregory M. Enns, Rebecca D. Ganetzky, Kelly Gilbert, Austin Larson, Rebecca Legi, April N. Lehman, Camile Newby, Manuel Schiff, Rachel Skeath, Peter W. Stacpoole, Sarah Thompson, Emma Watt, Saskia B. Wortmann, Jirair K. Bedoyan, Shamima Rahman   +23 more
wiley   +1 more source

Use of Botulinum Toxin in Orofacial Clinical Practice

Toxins, 2020
Introduction: Botulinum neurotoxin (BoNT) is a potent biological toxin and powerful therapeutic tool for a growing number of clinical orofacial applications.
Maria-Angeles Serrera-Figallo, Gonzalo Ruiz-de-León-Hernández, Daniel Torres-Lagares, Alejandra Castro-Araya, Omar Torres-Ferrerosa, Esther Hernández-Pacheco, Jose-Luis Gutierrez-Perez   +6 more
doaj   +1 more source

Neurodegenerative Diseases: Epidemiology, Risk Factors, Classification, Pathophysiology, Clinical Features, Diagnosis, and Therapeutic Strategies

MedComm, Volume 7, Issue 11, November 2026.
Neurodegenerative diseases share convergent risk architectures and pathological mechanisms, yet diverge in selective vulnerability, clinical presentation, and therapeutic responsiveness. This review integrates cross‐disease epidemiology, pathophysiology, diagnosis, and treatment, highlighting the transition from symptomatic care toward biomarker‐guided
Zimeng He, Jingjing Zeng, Guoqing Wang, Yuxin Li, Feng Zhang   +4 more
wiley   +1 more source

Injection of botulinum toxin type a to reduce saliva in patients with neurological diseases [PDF]

Einstein (São Paulo), 2005
Objective: To demonstrate the effect of local injection of Botox® inpatients with neurological diseases, following our protocol for thetreatment of sialorrhea.
Dayse Manrique
doaj  

Long Term Follow Up of Hereditary Thrombotic Thrombocytopenic Purpura on Plasma Therapy for 9 Years: A Case Report

Clinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT A 7.6‐year‐old boy with hTTP had fever‐induced hemorrhagic rash, MAHA, cerebral infarction, and renal impairment. After plasma therapy, symptoms were partially relieved; 9‐year follow‐up showed regular plasma transfusion was needed, with CKD Stage 3.
Dai Xiaomei, Chen Ruyue, Wu Shuang, Tang Hanyun, Lin Qiang, Li Xiaozhong   +5 more
wiley   +1 more source